Citations are updated once a week. Recently added citations may not appear.
The suggestion is based on each study and bacteria having different weight based on a multitude of factors. For example, how severe a shift is seen.
| Context | Citation |
|---|---|
| Decreases Pseudomonas aeruginosa - : Escherichia coli Nissle 1917 {Mutaflor} |
📓
Oleanolic Acid Promotes the Formation of Probiotic Escherichia coli Nissle 1917 (EcN) Biofilm by Inhibiting Bacterial Motility. Microorganisms (Microorganisms ) Vol: 12 Issue 6 Pages: Pub: 2024 May 29 Epub: 2024 May 29 Authors Liu D , Liu J , Ran L , Yang Z , He Y , Yang H , Yu Y , Fu L , Zhu M , Chen H , Html Article Publication |
| Decreases Pseudomonas aeruginosa - : Escherichia coli Nissle 1917 {Mutaflor} |
📓
Escherichia coli Nissle 1917 inhibits biofilm formation and mitigates virulence in Pseudomonas aeruginosa. Frontiers in microbiology (Front Microbiol ) Vol: 14 Issue Pages: 1108273 Pub: 2023 Epub: 2023 Mar 8 Authors Aljohani AM , El-Chami C , Alhubail M , Ledder RG , O`Neill CA , McBain AJ , Publication |
| Decreases Pseudomonas aeruginosa - : Escherichia coli Nissle 1917 {Mutaflor} |
📓
Probiotic Escherichia coli Nissle 1917 inhibits bacterial persisters that survive fluoroquinolone treatment. Journal of applied microbiology (J Appl Microbiol ) Vol: 132 Issue 6 Pages: 4020-4032 Pub: 2022 Jun Epub: 2022 Apr 5 Authors Hare PJ , Englander HE , Mok WWK , Publication |
| 0 😁 | 😢 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
